ReviewTheranostics2021

From biomarkers to therapeutic targets: the promise of PD-L1 in thyroid autoimmunity and cancer.

Grégoire D'Andréa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.